New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders

被引:8
作者
Dakwar, Elias [1 ]
Nunes, Edward V. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Div Substance Abuse,Dept Psychiat, New York, NY USA
关键词
Addiction; Behavioral treatment; Cocaine; Cannabis; Combined treatment; Medication; Use disorder; CONTINGENCY MANAGEMENT; COCAINE DEPENDENCE; N-ACETYLCYSTEINE; DRUG-ADDICTION; DOUBLE-BLIND; MESOLIMBIC DOPAMINE; CONTROLLED-TRIAL; KETAMINE; THERAPY; ALCOHOL;
D O I
10.1007/s11920-016-0703-4
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
A promising approach to addressing substance use disorders is to integrate pharmacotherapy with a behavioral treatment with which synergy is possible. In this review, we focus on recent research suggesting that this approach may be effective for cocaine and cannabis use disorders, both of which currently lack efficacious medications. We summarize potential targets of pharmacotherapy of particular relevance to combined medication-behavioral treatment and examine preliminary evidence of clinical efficacy. Common to these promising medications is a hypothesized mechanism of action predicated on reversing drug-related neural adaptations, such as high reactivity to stress or drug cues, that might undermine fruitful engagement with behavioral treatment. We also review emerging medications, such as certain glutamatergic and serotonergic agents, which may be feasibly integrated with existing treatments. We conclude with an outline of future directions for research.
引用
收藏
页数:8
相关论文
共 83 条
[1]  
[Anonymous], 2005, RELAPSE PREVENTION M
[2]  
[Anonymous], 1993, J ADDICT NURS
[3]  
[Anonymous], JAMA PSYCHIAT
[4]   Neurocognitive impairment associated with alcohol use disorders: Implications for treatment [J].
Bates, ME ;
Bowden, SC ;
Barry, D .
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2002, 10 (03) :193-212
[5]  
Belujon P, 2015, NEUROPSYCHOPHARMACOL
[6]   A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats [J].
Berglind, William J. ;
See, Ronald E. ;
Fuchs, Rita A. ;
Ghee, Shannon M. ;
Whitfield, Timothy W., Jr. ;
Miller, Scott W. ;
McGinty, Jacqueline F. .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2007, 26 (03) :757-766
[7]   Toward a behavioral economic understanding of drug dependence: delay discounting processes [J].
Bickel, WK ;
Marsch, LA .
ADDICTION, 2001, 96 (01) :73-86
[8]   A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period [J].
Bisaga, Adam ;
Aharonovich, Efrat ;
Cheng, Wendy Y. ;
Levin, Frances R. ;
Mariani, John J. ;
Raby, Wilfrid N. ;
Nunes, Edward V. .
DRUG AND ALCOHOL DEPENDENCE, 2010, 111 (1-2) :97-104
[9]   A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders [J].
Blodgett, Janet C. ;
Del Re, A. C. ;
Maisel, Natalya C. ;
Finney, John W. .
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 38 (06) :1481-1488
[10]   Neurotoxicity and neurocognitive impairments with alcohol and drug-use disorders: Potential roles in addiction and recovery [J].
Bowden, SC ;
Crews, FT ;
Bates, ME ;
Fals-Stewart, W ;
Ambrose, ML .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (02) :317-321